Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress.
Increase in opioid epidemic in the U.S. coupled with establishment of government policies to control the crisis is driving the market.
This report elaborates on the current development of the Opioid Use Disorder industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Teva Pharmaceuticals
Indivior
Pfizer, Inc
Mallinckrodt Pharmaceuticals
Orexo
Camurus
Alkermes
BioDelivery Sciences International Inc
Omeros
MediciNova
Titan Pharmaceuticals
Hikma Pharmaceuticals
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Buprenorphine
Methadone
Naltrexone
Application:
Severe Pain Treatment
Moderate Pain Treatment
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Opioid Use Disorder Industry Overview
-
1.1.1 Opioid Use Disorder Market Scope and Market Segments
-
1.1.2 Opioid Use Disorder Industry Characteristics
-
1.1.3 Global and China Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Opioid Use Disorder Production Value and Growth Rate (2017-2028)
-
1.2 Global Opioid Use Disorder Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Buprenorphine
-
1.2.2 Methadone
-
1.2.3 Naltrexone
-
1.3 Global Opioid Use Disorder Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Severe Pain Treatment
-
1.3.2 Moderate Pain Treatment
-
1.4 Market Analysis by Region
-
1.4.1 North America Opioid Use Disorder Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Opioid Use Disorder Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Opioid Use Disorder Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Opioid Use Disorder Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Opioid Use Disorder Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Opioid Use Disorder Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Opioid Use Disorder Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Opioid Use Disorder Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Opioid Use Disorder Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Opioid Use Disorder Industry Porter's Five Forces Model Analysis
-
2.2.3 Opioid Use Disorder Industry PEST Analysis
-
2.3 Opioid Use Disorder Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Opioid Use Disorder Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Opioid Use Disorder Industry
Chapter 3 Global and China Opioid Use Disorder Market, by Manufacturer
-
3.1 Global and China Opioid Use Disorder Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Opioid Use Disorder Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Opioid Use Disorder Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Opioid Use Disorder Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Opioid Use Disorder Market Top 3 Players
Chapter 4 Global and China Opioid Use Disorder Market, by Type (2017-2028)
-
4.1 Opioid Use Disorder Market Trend, by Type
-
4.2 Global Opioid Use Disorder Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Opioid Use Disorder Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Opioid Use Disorder Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Opioid Use Disorder Price Trend, by Type (2017-2028)
-
4.3 China Opioid Use Disorder Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Opioid Use Disorder Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Opioid Use Disorder Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Opioid Use Disorder Price Trend, by Type (2017-2028)
Chapter 5 Global and China Opioid Use Disorder Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Opioid Use Disorder Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Opioid Use Disorder Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Opioid Use Disorder Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Opioid Use Disorder Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Opioid Use Disorder Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Opioid Use Disorder Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Opioid Use Disorder Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Opioid Use Disorder Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Opioid Use Disorder Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Opioid Use Disorder Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Opioid Use Disorder Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Opioid Use Disorder Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Opioid Use Disorder Market Analysis
-
7.1 North America Opioid Use Disorder Market, by Type
-
7.2 North America Opioid Use Disorder Market, by Application
-
7.3 North America Opioid Use Disorder Market Analysis and Forecast, by Country
-
7.3.1 United States Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Opioid Use Disorder Market Analysis
-
8.1 Europe Opioid Use Disorder Market, by Type
-
8.2 Europe Opioid Use Disorder Market, by Application
-
8.3 Europe Opioid Use Disorder Market Analysis and Forecast, by Country
-
8.3.1 Germany Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Opioid Use Disorder Market Analysis
-
9.1 APAC Opioid Use Disorder Market, by Type
-
9.2 APAC Opioid Use Disorder Market, by Application
-
9.3 APAC Opioid Use Disorder Market Analysis and Forecast, by Country
-
9.3.1 China Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Opioid Use Disorder Market Analysis
-
10.1 Latin America, Middle East and Africa Opioid Use Disorder Market, by Type
-
10.2 Latin America, Middle East and Africa Opioid Use Disorder Market, by Application
-
10.3 Latin America, Middle East and Africa Opioid Use Disorder Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Opioid Use Disorder Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Opioid Use Disorder Company Profiles
-
11.1 Teva Pharmaceuticals
-
11.1.1 Teva Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Teva Pharmaceuticals Opioid Use Disorder Product Profiles, Application and Specification
-
11.1.3 Teva Pharmaceuticals Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Indivior
-
11.2.1 Indivior Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Indivior Opioid Use Disorder Product Profiles, Application and Specification
-
11.2.3 Indivior Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Pfizer, Inc
-
11.3.1 Pfizer, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Pfizer, Inc Opioid Use Disorder Product Profiles, Application and Specification
-
11.3.3 Pfizer, Inc Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Mallinckrodt Pharmaceuticals
-
11.4.1 Mallinckrodt Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Mallinckrodt Pharmaceuticals Opioid Use Disorder Product Profiles, Application and Specification
-
11.4.3 Mallinckrodt Pharmaceuticals Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Orexo
-
11.5.1 Orexo Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Orexo Opioid Use Disorder Product Profiles, Application and Specification
-
11.5.3 Orexo Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Camurus
-
11.6.1 Camurus Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Camurus Opioid Use Disorder Product Profiles, Application and Specification
-
11.6.3 Camurus Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Alkermes
-
11.7.1 Alkermes Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Alkermes Opioid Use Disorder Product Profiles, Application and Specification
-
11.7.3 Alkermes Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 BioDelivery Sciences International Inc
-
11.8.1 BioDelivery Sciences International Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 BioDelivery Sciences International Inc Opioid Use Disorder Product Profiles, Application and Specification
-
11.8.3 BioDelivery Sciences International Inc Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Omeros
-
11.9.1 Omeros Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Omeros Opioid Use Disorder Product Profiles, Application and Specification
-
11.9.3 Omeros Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 MediciNova
-
11.10.1 MediciNova Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 MediciNova Opioid Use Disorder Product Profiles, Application and Specification
-
11.10.3 MediciNova Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Titan Pharmaceuticals
-
11.11.1 Titan Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Titan Pharmaceuticals Opioid Use Disorder Product Profiles, Application and Specification
-
11.11.3 Titan Pharmaceuticals Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Hikma Pharmaceuticals
-
11.12.1 Hikma Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Hikma Pharmaceuticals Opioid Use Disorder Product Profiles, Application and Specification
-
11.12.3 Hikma Pharmaceuticals Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Opioid Use Disorder Industry Investment Prospect and Risk Assessment
-
12.1 Opioid Use Disorder Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Opioid Use Disorder Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure China Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure Global Opioid Use Disorder Production Value and Growth Rate (2017-2028)
-
Figure China Opioid Use Disorder Production Value and Growth Rate (2017-2028)
-
Figure Global Opioid Use Disorder Market Size and Growth Rate of Buprenorphine (2017-2028)
-
Figure Global Opioid Use Disorder Market Size and Growth Rate of Methadone (2017-2028)
-
Figure Global Opioid Use Disorder Market Size and Growth Rate of Naltrexone (2017-2028)
-
Figure Global Opioid Use Disorder Market Size and Growth Rate of Severe Pain Treatment (2017-2028)
-
Figure Global Opioid Use Disorder Market Size and Growth Rate of Moderate Pain Treatment (2017-2028)
-
Figure North America Opioid Use Disorder Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Opioid Use Disorder Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Opioid Use Disorder Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Opioid Use Disorder Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Opioid Use Disorder Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Opioid Use Disorder Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Opioid Use Disorder Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Opioid Use Disorder Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Opioid Use Disorder Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Opioid Use Disorder Market Share, by Manufacturer in 2021
-
Figure Global and China Opioid Use Disorder Market Share, by Manufacturer in 2022
-
Table Global Opioid Use Disorder Sales Volume, by Type (2017-2028)
-
Table Global Opioid Use Disorder Sales Volume Share, by Type (2017-2028)
-
Figure Global Opioid Use Disorder Sales Volume Share, by Type (2017-2028)
-
Table Global Opioid Use Disorder Sales Value, by Type (2017-2028)
-
Table Global Opioid Use Disorder Sales Value Share, by Type (2017-2028)
-
Figure Global Opioid Use Disorder Price Trend, by Type (2017-2028)
-
Table China Opioid Use Disorder Sales Volume, by Type (2017-2028)
-
Table China Opioid Use Disorder Sales Volume Share, by Type (2017-2028)
-
Figure China Opioid Use Disorder Sales Volume Share, by Type (2017-2028)
-
Table China Opioid Use Disorder Sales Value, by Type (2017-2028)
-
Table China Opioid Use Disorder Sales Value Share, by Type (2017-2028)
-
Figure China Opioid Use Disorder Price Trend, by Type (2017-2028)
-
Table Global Opioid Use Disorder Sales Volume, by Application (2017-2028)
-
Table Global Opioid Use Disorder Sales Volume Share, by Application (2017-2028)
-
Figure Global Opioid Use Disorder Sales Volume Share, by Application (2017-2028)
-
Table Global Opioid Use Disorder Sales Value, by Application (2017-2028)
-
Table Global Opioid Use Disorder Sales Value Share, by Application (2017-2028)
-
Figure Global Opioid Use Disorder Sales Value Share, by Application (2017-2028)
-
Table China Opioid Use Disorder Sales Volume, by Application (2017-2028)
-
Table China Opioid Use Disorder Sales Volume Share, by Application (2017-2028)
-
Figure China Opioid Use Disorder Sales Volume Share, by Application (2017-2028)
-
Table China Opioid Use Disorder Sales Value, by Application (2017-2028)
-
Table China Opioid Use Disorder Sales Value Share, by Application (2017-2028)
-
Figure China Opioid Use Disorder Sales Value Share, by Application (2017-2028)
-
Figure China Opioid Use Disorder Production, Import, Consumption and Export (2017-2022)
-
Figure North America Opioid Use Disorder Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Opioid Use Disorder Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Opioid Use Disorder Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Opioid Use Disorder Production, Import, Consumption and Export (2017-2022)
-
Table North America Opioid Use Disorder Sales Volume, by Type (2017-2028)
-
Table North America Opioid Use Disorder Sales Volume Share, by Type (2017-2028)
-
Figure North America Opioid Use Disorder Sales Volume Share, by Type (2017-2028)
-
Table North America Opioid Use Disorder Sales Volume, by Application (2017-2028)
-
Table North America Opioid Use Disorder Sales Volume Share, by Application (2017-2028)
-
Figure North America Opioid Use Disorder Sales Volume Share, by Application (2017-2028)
-
Figure United States Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure United States Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Figure Canada Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Table Europe Opioid Use Disorder Sales Volume, by Type (2017-2028)
-
Table Europe Opioid Use Disorder Sales Volume Share, by Type (2017-2028)
-
Figure Europe Opioid Use Disorder Sales Volume Share, by Type (2017-2028)
-
Table Europe Opioid Use Disorder Sales Volume, by Application (2017-2028)
-
Table Europe Opioid Use Disorder Sales Volume Share, by Application (2017-2028)
-
Figure Europe Opioid Use Disorder Sales Volume Share, by Application (2017-2028)
-
Figure Germany Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Figure UK Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure UK Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Figure France Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure France Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Figure Italy Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Figure Spain Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Figure Poland Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Figure Russia Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Table APAC Opioid Use Disorder Sales Volume, by Type (2017-2028)
-
Table APAC Opioid Use Disorder Sales Volume Share, by Type (2017-2028)
-
Figure APAC Opioid Use Disorder Sales Volume Share, by Type (2017-2028)
-
Table APAC Opioid Use Disorder Sales Volume, by Application (2017-2028)
-
Table APAC Opioid Use Disorder Sales Volume Share, by Application (2017-2028)
-
Figure APAC Opioid Use Disorder Sales Volume Share, by Application (2017-2028)
-
Figure China Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure China Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Figure Japan Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Figure India Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure India Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Opioid Use Disorder Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Opioid Use Disorder Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Opioid Use Disorder Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Opioid Use Disorder Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Opioid Use Disorder Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Opioid Use Disorder Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Opioid Use Disorder Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Opioid Use Disorder Sales Value and Growth Rate (2017-2028)
-
Table Teva Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Teva Pharmaceuticals Product Profiles, Application and Specification
-
Table Teva Pharmaceuticals Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Indivior Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Indivior Product Profiles, Application and Specification
-
Table Indivior Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfizer, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer, Inc Product Profiles, Application and Specification
-
Table Pfizer, Inc Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Mallinckrodt Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Mallinckrodt Pharmaceuticals Product Profiles, Application and Specification
-
Table Mallinckrodt Pharmaceuticals Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Orexo Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Orexo Product Profiles, Application and Specification
-
Table Orexo Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Camurus Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Camurus Product Profiles, Application and Specification
-
Table Camurus Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Alkermes Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Alkermes Product Profiles, Application and Specification
-
Table Alkermes Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table BioDelivery Sciences International Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table BioDelivery Sciences International Inc Product Profiles, Application and Specification
-
Table BioDelivery Sciences International Inc Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Omeros Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Omeros Product Profiles, Application and Specification
-
Table Omeros Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table MediciNova Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table MediciNova Product Profiles, Application and Specification
-
Table MediciNova Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Titan Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Titan Pharmaceuticals Product Profiles, Application and Specification
-
Table Titan Pharmaceuticals Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Hikma Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Hikma Pharmaceuticals Product Profiles, Application and Specification
-
Table Hikma Pharmaceuticals Opioid Use Disorder Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
